Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$1.9 - $8.63 $2,660 - $12,082
-1,400 Reduced 99.5%
7 $0
Q1 2022

Jul 14, 2022

BUY
$6.28 - $15.59 $8,835 - $21,935
1,407 New
1,407 $5,000
Q4 2021

Jan 21, 2022

SELL
$14.7 - $28.67 $14,700 - $28,670
-1,000 Closed
0 $0
Q3 2021

Oct 22, 2021

SELL
$24.31 - $33.6 $4,862 - $6,720
-200 Reduced 16.67%
1,000 $28,000
Q2 2021

Jul 15, 2021

BUY
$26.09 - $40.4 $18,263 - $28,280
700 Added 140.0%
1,200 $40,000
Q1 2021

Apr 14, 2021

BUY
$33.06 - $56.93 $16,530 - $28,465
500 New
500 $19,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.